SUFU 2008 Winter Meeting Outcomes Measures For Incontinence Treatment (OMIT)

Main Category: Urology / Nephrology
Also Included In: Conferences
Article Date: 08 Mar 2008 - 1:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

UroToday.com - The lack of common outcomes measures and tools to assess outcomes of the various treatment options has been the topic of much discussion over the years. Minimal progress in the overall quality of the literature was found between two consecutive Clinical Guidelines Panels from 1997 to 2007. In order to facilitate communication between centers and effective collaboration within the subspecialty, the Outcomes Measures for Incontinence Treatment, or "OMIT" committee was formed. The initial objective of the committee was to identify common denominators amongst those who report outcomes in the field.

A recent survey was administered to the attendees of the 2007 winter SUFU meeting, and the results were reported. A proposal to consider using the most commonly used instruments and measures as determined by the survey was presented, with an emphasis on the point that the recommendations are by no means exclusive. If adopted, the common denominators would provide a common ground, but investigators would surely be free to add any instruments of their preference to their outcomes reports.

Presented by: Philippe E. Zimmern, MD at the Society for Urodynamics and Female Urology (SUFU) 2008 Winter Meeting - February 28 - March 2, 2008 Miami, Florida, USA

Reported for UroToday.com by Kathleen C. Kobashi, MD, Head, Section of Urology and Renal Transplantation, Virginia Mason Medical Center

Co-Director Continence Center, Virginia Mason Medical Center Clinical Associate Professor of Urology, University of Washington

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday